echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Lancet Sub-Journal: Be alert!

    Lancet Sub-Journal: Be alert!

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Carotid stenosis is a recognized stroke risk factors and medsci.


    Carotid stenosis is a recognized stroke risk factors and medsci.


    Prevention Compared with the best drug therapy alone, endovascular treatment has less long-term benefits and may also cause additional surgical damage.


    Since 2007, the United States Preventive Services Task Force (USPSTF) has consistently recommended Level D evidence, that is, against screening for asymptomatic carotid stenosis in the general adult population.


    JAMA recommends that adults without stroke, neurological symptoms, or transient ischemic attack symptoms do not need to be screened for asymptomatic carotid artery stenosis.


    Lancet

    The Oxford Vascular Study (OxVasc) is a population-based prospective study and systematic retrospective analysis.


    All participants were treated with standardized medications and followed up to determine the risk of ipsilateral stroke in this population.


    Between April 1, 2002 and April 1, 2017, a total of 2354 patients were included in the study.


    The results showed that the risk of ipsilateral stroke increased with the degree of carotid artery stenosis after 5 years.


    After 5 years, the risk of ipsilateral stroke increases with the degree of carotid artery stenosis.


    Patients with 70-99% stenosis have a 110% higher risk of stroke than those with 50-69% stenosis, and patients with a stenosis rate of 80-99% have a 150% higher risk than patients with a stenosis rate of 50-79%! Patients with 70-99% stenosis have a 110% higher risk of stroke than those with 50-69% stenosis, and patients with a stenosis rate of 80-99% have a 150% higher risk than patients with a stenosis rate of 50-79%!

    Further analysis found that compared with the cohort study, the results of the randomized controlled trial of endarterectomy are highly inconsistent with the results of the cohort study.


    There is significant heterogeneity in the risk of stroke between studies of patients with severe and moderate stenosis.


    To this end, the researchers pointed out that despite advances in drug therapy, the risk of stroke in patients with highly asymptomatic carotid stenosis is still high, indicating that current guidelines may underestimate the benefits of surgical intervention.


    In the future, more large-sample, non-selection-biased intervention RCTs will be needed to demonstrate evidence in this regard.


    In the future, more large-sample, non-selection-biased intervention RCTs will be needed to demonstrate evidence in this regard.


    references:

    Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis.


    Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis.

     

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.